K8凯发(中国)

Cells underpin the survival of living organisms.

Genes determine the future.

Cell Valley Group was co-founded by American and Hong Kong Chinese scientists hailing from Harvard, Cornell and other world-renowned universities. Drawing on its cutting-edge research expertise, the Group has set up three core centers and five wholly-owned subsidiaries across North and South China, and operates over 10,000 square meters of GMP-compliant workshops and internationally accredited laboratories. It boasts industry-leading core technologies, including China’s first clinical-grade retroviral vector production line and world-leading gene editing systems. As the first foreign-invested enterprise to benefit from the pilot program for medical industry opening-up, the Group launched the Shenzhen-Hong Kong Cell Valley project and pioneered a dual-driven development model of "healthcare + consumption". With Shenzhen Cell Valley serving as its R&D and manufacturing headquarters, the Group offers one-stop, full-process CRO/CDMO services. It has partnered with more than 100 institutions to address key industry challenges and fuel the development of the biotech sector.